Sirolimus-coated Balloon: FIRST HUMAN USE

Sirolimus-coated Balloon: FIRST HUMAN USE

Great news-a few days ago I had the chance to use a sirolimus-coated balloon for coronary PCI in the first european patient (to say the truth, the first patient of the western world)!!

This very promising device just obtained the CE Mark for this application. A long way is ahead and I am really excited to be part of this adventure in designing a strict scientific program on the matter. In fact, no one wants to repeat the mistakes of the paclitaxel-eluting technology, that has only now reached a reliable scientific background.

CLIC meeting at Caltanissetta, Sicily

CLIC meeting at Caltanissetta, Sicily

A couple of weeks ago, I had the pleasure to be invited at the CLIC, a cardiovascular meeting organized by Dr Amico in Caltanissetta. The event had the scientific background of some renown physicians from the group of Prof Tamburino in Catania, and I had the pleasure to be the only “continental” physician invited!

The meeting was of high scientific level and the discussion was interactive and interesting.

I contributed with a speech entitled “Incomplete revascularization and drug-coated balloons”, a setting where DCB may have a specific role. I also gave some contributions regarding biovascular scaffolds during the discussion. Give a look at the nice pics.

 

BVS SAVE: The BVS-SAVE Italian registry:  Bioresorbable Vascular Scaffolds  for the Treatment of Small Vessel Disease

BVS SAVE: The BVS-SAVE Italian registry: Bioresorbable Vascular Scaffolds for the Treatment of Small Vessel Disease

Much debate is currently running on BVS performance in small coronary vessels. I am here attaching one of the few publications available worldwide, that our group coordinated recently: the BVS SAVE study. This poster was presented at both the 2015 GISE and TCT meetings. Please take a look at the results.